20250HR__010599INT INTRODUCED 2026-04-13 REVISED 2026-05-11 2025 HR INT Introduced by Assembly Member Zbur (Principal coauthor: Assembly Member Dixon) (Coauthors: Assembly Members Alanis, Boerner, Jeff Gonzalez, Papan, Ransom, Ward , DeMaio, Addis, Aguiar-Curry, Ahrens, Alvarez, Ávila Farías, Bains, Bauer-Kahan, Bennett, Berman, Bonta, Bryan, Calderon, Caloza, Carrillo, Castillo, Chen, Connolly, Davies, Elhawary, Ellis, Flora, Fong, Gabriel, Garcia, Gipson, Mark González, Hadwick, Haney, Harabedian, Hart, Hoover, Irwin, Jackson, Johnson, Kalra, Krell, Lackey, Lee, Macedo, McKinnor, Muratsuchi, Nguyen, Pacheco, Patel, Patterson, Pellerin, Petrie-Norris, Ramos, Rivas, Rogers, Blanca Rubio, Sanchez, Schiavo, Schultz, Sharp-Collins, Stefani, Ta, Tangipa, Valencia, Wallis, Wicks, and Wilson) LEAD_AUTHOR ASSEMBLY Zbur PRINCIPAL_COAUTHOR ASSEMBLY Dixon COAUTHOR ASSEMBLY Alanis COAUTHOR ASSEMBLY Boerner <caml:Contribution>COAUTHOR</caml:Contribution><caml:House>ASSEMBLY</caml:House><caml:Name>Dixon</caml:Name></caml:Legislator>"?> COAUTHOR ASSEMBLY Jeff Gonzalez COAUTHOR ASSEMBLY Papan COAUTHOR ASSEMBLY Ransom COAUTHOR ASSEMBLY Ward COAUTHOR ASSEMBLY DeMaio COAUTHOR ASSEMBLY Addis COAUTHOR ASSEMBLY Aguiar-Curry COAUTHOR ASSEMBLY Ahrens COAUTHOR ASSEMBLY Alvarez COAUTHOR ASSEMBLY Ávila Farías COAUTHOR ASSEMBLY Bains COAUTHOR ASSEMBLY Bauer-Kahan COAUTHOR ASSEMBLY Bennett COAUTHOR ASSEMBLY Berman COAUTHOR ASSEMBLY Bonta COAUTHOR ASSEMBLY Bryan COAUTHOR ASSEMBLY Calderon COAUTHOR ASSEMBLY Caloza COAUTHOR ASSEMBLY Carrillo COAUTHOR ASSEMBLY Castillo COAUTHOR ASSEMBLY Chen COAUTHOR ASSEMBLY Connolly COAUTHOR ASSEMBLY Davies COAUTHOR ASSEMBLY Elhawary COAUTHOR ASSEMBLY Ellis COAUTHOR ASSEMBLY Flora COAUTHOR ASSEMBLY Fong COAUTHOR ASSEMBLY Gabriel COAUTHOR ASSEMBLY Garcia COAUTHOR ASSEMBLY Gipson COAUTHOR ASSEMBLY Mark González COAUTHOR ASSEMBLY Hadwick COAUTHOR ASSEMBLY Haney COAUTHOR ASSEMBLY Harabedian COAUTHOR ASSEMBLY Hart COAUTHOR ASSEMBLY Hoover COAUTHOR ASSEMBLY Irwin COAUTHOR ASSEMBLY Jackson COAUTHOR ASSEMBLY Johnson COAUTHOR ASSEMBLY Kalra COAUTHOR ASSEMBLY Krell COAUTHOR ASSEMBLY Lackey COAUTHOR ASSEMBLY Lee COAUTHOR ASSEMBLY Macedo COAUTHOR ASSEMBLY McKinnor COAUTHOR ASSEMBLY Muratsuchi COAUTHOR ASSEMBLY Nguyen COAUTHOR ASSEMBLY Pacheco COAUTHOR ASSEMBLY Patel COAUTHOR ASSEMBLY Patterson COAUTHOR ASSEMBLY Pellerin COAUTHOR ASSEMBLY Petrie-Norris COAUTHOR ASSEMBLY Ramos COAUTHOR ASSEMBLY Rivas COAUTHOR ASSEMBLY Rogers COAUTHOR ASSEMBLY Blanca Rubio COAUTHOR ASSEMBLY Sanchez COAUTHOR ASSEMBLY Schiavo COAUTHOR ASSEMBLY Schultz COAUTHOR ASSEMBLY Sharp-Collins COAUTHOR ASSEMBLY Stefani COAUTHOR ASSEMBLY Ta COAUTHOR ASSEMBLY Tangipa COAUTHOR ASSEMBLY Valencia COAUTHOR ASSEMBLY Wallis COAUTHOR ASSEMBLY Wicks COAUTHOR ASSEMBLY Wilson Relative to Amyotrophic Lateral Sclerosis Awareness Month.

Amyotrophic Lateral Sclerosis Awareness Month

WHEREAS, Amyotrophic lateral sclerosis (ALS), also commonly known as Lou Gehrig’s disease, is a progressive fatal neurodegenerative disease in which a person’s brain loses connection with their muscles, slowly reducing a person’s ability to walk, talk, eat, and eventually breathe; and

WHEREAS, Thousands of new ALS cases are reported every year, and estimates show that every minutes someone is diagnosed with ALS and someone passes away from ALS; and

WHEREAS, On average, patients diagnosed with ALS survive only two to five years from the time of diagnosis; and

WHEREAS, The exact causes of ALS are unknown and there is no known cure for ALS; and

WHEREAS, People who have served in the military are more likely to develop ALS and die from the disease than those with no history of military service; and

WHEREAS, Securing access to new therapies, durable medical equipment, and communication technologies is of vital importance to people living with ALS; and

WHEREAS, Clinical trials play a pivotal role in evaluating new treatments, enhancing quality of life, and fostering assistive technologies for those living with ALS; and

WHEREAS, Amyotrophic Lateral Sclerosis Awareness Month provides an opportunity to increase public awareness of the dire circumstances of people living with ALS, acknowledge the terrible impact this disease has on those individuals and their families, and support research to eradicate this disease;

now, therefore,

be it Resolved by the Assembly of the State of California, That the Assembly hereby proclaims the month of May as Amyotrophic Lateral Sclerosis Awareness Month, and calls upon all Americans to join in supporting ALS research, advocating for increased funding, and standing in solidarity with those affected by this relentless disease; and be it further Resolved, That the Chief Clerk of the Assembly shall transmit copies of this resolution to the author for appropriate distribution. REVISIONS: Heading—Line 4.